Key regions: United Kingdom, Germany, France, South Korea, Italy
The COVID-19 Vaccines market in Slovakia has been experiencing steady growth in recent months.
Customer preferences: Slovakia has a population of approximately 5.5 million people, and like many other countries worldwide, the majority of the population has shown a willingness to receive the COVID-19 vaccine. The government has been actively promoting the vaccine through various channels, including social media and television advertisements, which has helped to increase public awareness and confidence in the vaccine.
Trends in the market: One of the key trends in the COVID-19 Vaccines market in Slovakia is the increasing availability of vaccines. The government has been working closely with vaccine manufacturers to secure a steady supply of vaccines, and this has resulted in an increase in the number of vaccination sites across the country. As a result, more people are now able to access the vaccine, which has contributed to the steady growth of the market.Another trend in the market is the increasing demand for booster shots. As more time passes since the initial vaccination, people are looking for ways to maintain their immunity and protect themselves against new variants of the virus. This has led to an increase in demand for booster shots, which has contributed to the growth of the market.
Local special circumstances: Slovakia has a relatively high vaccination rate compared to other countries in the region, which has helped to control the spread of the virus and minimize the impact of the pandemic on the economy. The government has also implemented strict measures to control the spread of the virus, including lockdowns and travel restrictions, which has helped to reduce the number of cases and limit the impact on the healthcare system.
Underlying macroeconomic factors: The Slovakian economy has been heavily impacted by the pandemic, with many businesses forced to close and unemployment rates increasing. However, the steady growth of the COVID-19 Vaccines market has provided some relief, as it has created new jobs and contributed to the overall recovery of the economy. Additionally, the government has provided financial support to businesses and individuals affected by the pandemic, which has helped to mitigate the economic impact.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
